JP2017190308A5 - - Google Patents

Download PDF

Info

Publication number
JP2017190308A5
JP2017190308A5 JP2016081528A JP2016081528A JP2017190308A5 JP 2017190308 A5 JP2017190308 A5 JP 2017190308A5 JP 2016081528 A JP2016081528 A JP 2016081528A JP 2016081528 A JP2016081528 A JP 2016081528A JP 2017190308 A5 JP2017190308 A5 JP 2017190308A5
Authority
JP
Japan
Prior art keywords
composition
chitosan
yeast
suppressing
lactic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016081528A
Other languages
Japanese (ja)
Other versions
JP6719105B2 (en
JP2017190308A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2016081528A priority Critical patent/JP6719105B2/en
Priority claimed from JP2016081528A external-priority patent/JP6719105B2/en
Publication of JP2017190308A publication Critical patent/JP2017190308A/en
Publication of JP2017190308A5 publication Critical patent/JP2017190308A5/ja
Application granted granted Critical
Publication of JP6719105B2 publication Critical patent/JP6719105B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (2)

ターミナリア処理物を含有する経口組成物であって、
さらに、キトサン、乳酸菌、酵母、穀物発酵物及び黒酢から選ばれる少なくとも1種の成分を含むことを特徴とする経口組成物。
An oral composition containing a processed terminator,
An oral composition characterized by further comprising at least one component selected from chitosan, lactic acid bacteria, yeast, fermented cereals and black vinegar.
ターミナリア処理物を含有する血中中性脂肪上昇抑制用組成物であって、
さらに、キトサン、乳酸菌、酵母、穀物発酵物及び黒酢から選ばれる少なくとも1種の成分を含むことを特徴とする血中中性脂肪上昇抑制用組成物。
A composition for suppressing an increase in blood triglyceride containing a terminally treated product,
Further, a composition for suppressing an increase in neutral fat in blood, comprising at least one component selected from chitosan, lactic acid bacteria, yeast, fermented cereals and black vinegar.
JP2016081528A 2016-04-14 2016-04-14 Composition for suppressing blood triglyceride elevation Active JP6719105B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2016081528A JP6719105B2 (en) 2016-04-14 2016-04-14 Composition for suppressing blood triglyceride elevation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016081528A JP6719105B2 (en) 2016-04-14 2016-04-14 Composition for suppressing blood triglyceride elevation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020095770A Division JP7044273B2 (en) 2020-06-01 2020-06-01 Composition for suppressing increase in triglyceride in blood

Publications (3)

Publication Number Publication Date
JP2017190308A JP2017190308A (en) 2017-10-19
JP2017190308A5 true JP2017190308A5 (en) 2020-03-05
JP6719105B2 JP6719105B2 (en) 2020-07-08

Family

ID=60085073

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016081528A Active JP6719105B2 (en) 2016-04-14 2016-04-14 Composition for suppressing blood triglyceride elevation

Country Status (1)

Country Link
JP (1) JP6719105B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6742608B2 (en) * 2018-03-30 2020-08-19 株式会社東洋新薬 Food composition
JP7418170B2 (en) * 2019-08-30 2024-01-19 小林製薬株式会社 Oral composition
JP7452874B2 (en) 2020-08-25 2024-03-19 株式会社東洋新薬 Oral composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4515013B2 (en) * 2002-08-13 2010-07-28 有限会社 坂本薬草園 Treatment or prevention of vascular fibrosis
WO2004033502A1 (en) * 2002-10-08 2004-04-22 Ricom Corporation Chitosan-containing polysaccharide, process for producing the same and use thereof
JP2006193510A (en) * 2004-12-06 2006-07-27 Toyo Shinyaku:Kk Active oxygen-eliminating agent

Similar Documents

Publication Publication Date Title
WO2015148863A3 (en) Crispr/cas-related methods and compositions for treating sickle cell disease
MA43347A (en) COMPOSITIONS AND METHODS TO INHIBIT LPA GENE EXPRESSION
WO2017044857A3 (en) Methods and compositions for the treatment of glaucoma
WO2015170320A3 (en) Compositions and methods of using same for controlling pathogenically infected mosquitoes
WO2017095944A8 (en) Methods and compositions relating to chondrisomes from blood products
WO2019066577A3 (en) Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community
TW201611731A (en) Processing method for marinate mandarin fish
WO2015197530A3 (en) Difluoromethyl-nicotinic-indanyl carboxamides
WO2015110925A3 (en) Method and system for creating a food or drink recipe
WO2014196913A9 (en) Treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimer's disease and inflammatory bowel disease by using at least one bacterial strain from prevotella
EP2999933A4 (en) Process for drying and powderizing functional foods, nutraceuticals, and natural health ingredients
MY177340A (en) Method for preparing imp fermented broth or glutamic acid fermented broth as raw material for preparation of natural flavor
EP3222156A4 (en) Flavor improvement method for yeast cells and food quality improving agent
WO2014127351A3 (en) Compositions and methods to alter gut microbial fermentation using sulfate-reducing bacteria
JP2017190308A5 (en)
MX2018002307A (en) Lactobacillus fermentum bacteria reducing the concentration of acetaldehyde.
PH12019500275A1 (en) Composition for imparting/enhancing cheese flavor, method for producing composition for imparting/enhancing cheese flavor, method for imparting cheese flavor to foods or enhancing cheese flavor of foods, and method for producing foods with imparted/enhanced cheese flavor
EP3069616A3 (en) Fermented food ingredient
EA202190286A1 (en) MICROBIOLOGICAL METHOD FOR PRODUCING PERGA
JP2018083761A5 (en)
WO2015197745A3 (en) Process for preparing antimicrobial microcapsules
JP2016049051A5 (en)
JP2015171341A5 (en)
JP2018070452A5 (en)
JP2016008197A5 (en)